Control Strategies and Vaccines for African Swine Fever—What Is to Come
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: 31 December 2026 | Viewed by 8
Special Issue Editors
Interests: African Swine Fever; animals emerging diseases; animal epidemiology; PCR; DNA; genomics; molecular biology; genetics; sequencing; RNA; cell culture; electrophoresis; gel electrophoresis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
African Swine Fever (ASF) is a devastating viral infectious disease that represents the biggest challenge for the pig sector worldwide. The causative agent is a large, complex DNA virus. ASF is present in more than 175 countries and territories across five continents, causing serious sanitary and economic losses. The disease affects both domestic pigs (DP) and wild boar (WB), making eradication difficult in endemic areas where viruses of different virulence and clinical characteristics coexist.
Considering the impact of ASF and the difficulties in controlling virus spread, the need for a vaccine and associated control strategies as essential measures to safeguard animal health has reached broad consensus. However, despite decades of investment and resources, a safe and effective commercial vaccine is still not available worldwide. For the only licenced vaccines in some Southeast Asian countries, safety concerns have emerged following their use, including mortality, abortions, and evidence of reversion to virulence, which negatively impacts the reproductive performance of sows.
The purpose of this Special Issue of Vaccines is to provide updated knowledge and research on key aspects of the disease, including the development of improved vaccines for WB and DP, together with accompanying diagnostic tests, the genomic factors influencing safety, cross-protection and stability, field and in vivo experimental trials with novel vaccine candidates, and control strategies and vaccination programmes for this complex condition. Particular emphasis is given to research addressing the major limitations of live-attenuated vaccines, especially their efficacy in cross-protection.
Dr. Camina Gallardo Frontaura
Dr. Marisa Arias
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- African Swine Fever
- ASF
- vaccine candidates
- vaccine safety
- genomic markers
- genetic stability
- vaccination
- protection
- immune response against infection
- immune response against vaccination
- ASF vaccine efficacy
- vaccine cross-protection
- DIVA test
- control strategies
- wildboar
- vaccination programmes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
